Legal Issues and BPCI Act


The legal issues pertaining to the follow-on-Biologics and Biosimilars are one of the most aspects that require an open discussion. Before the actual advent of Biosimilars to the market legal issues have risen in numbers in their developmental stages. Renowned organizations have filed cases against each other two claim their rights and for other legal allegations related to the products. This track is dedicated to discussion of all such cases which has been argued in the court of law. By 2002, the FDA had approved 36 new Biologics, followed by 37 more in 2003, another 40 in 2004 and 39 more in 2005. By 2006, the leading category of biologic treatment, the red blood cell enhancer recombinant erythropoietin (EPO), generated $14 billion in sales revenues, or 40 percent more than the best-selling traditional pharmaceutical, Lipitor. More than 300 therapeutic antibodies currently are in clinical development and trials, compared to just 13 that already are widely available due to legal issues


    Related Conference of Legal Issues and BPCI Act

    February 14-15, 2023

    8th Pharmaceutical Chemistry Conference

    Paris, France
    February 20-21, 2023

    20th Annual Meet on Pharmaceutical Sciences

    Rome, Italy
    March 10-11, 2023

    Global Pharmaceutical and Pharma Industry Conference

    Brussels, Belgium
    March 13-14, 2023

    33rd Annual European Pharma Congress

    Frankfurt, Germany
    March 27-28, 2023

    16th Global Pharmacovigilance & Clinical Trials Summit

    Vancouver, Canada
    April 03-04, 2023

    16th European Biosimilars Congress

    Barcelona, Spain
    April 25-26, 2023

    4th Annual Congress on Antibiotics and Bacterial Infections

    Amsterdam, Netherlands
    May 07-08, 2023

    Advanced-Materials 2023

    Valencia, Spain
    July 25-26, 2023

    36th World Congress on Pharmacology

    Amsterdam, Netherlands
    August 11-12, 2023

    38th World Congress on Pharmacology and Therapeutics

    Singapore City, Singapore
    August 28-29, 2023

    23rd International Pharmaceutical Conference and Expo

    Vancouver, Canada
    September 06-07, 2023

    16th World Drug Delivery Summit

    London, UK
    September 14-15, 2023

    10th international conference on Physiotherapy

    Bangkok, Thailand
    September 27-28, 2023

    3rd World Congress on Rare Diseases & Orphan Drugs

    Amsterdam, Netherlands
    September 27-28, 2023

    8th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    October 09-10, 2023

    20th International Conference on Pharmaceutical Chemistry

    Barcelona, Spain
    October 12-13, 2023

    26th World Congress on Nursing, Pharmacology and Healthcare

    Budapest, Hungary
    November 09-10, 2023

    11th International Conference on Clinical Trials

    London, UK
    November 10-11, 2023

    3rd World Biosimilars & Biologics Congress

    Berlin, Germany
    December 05-06, 2023

    2nd World Congress on Precision and Personalized Medicine

    Zurich, Switzerland

    Legal Issues and BPCI Act Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in